Additional file 2: of Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

a –g Sensitivity analyses showing cross-sectional associations between tenascin-C levels and SLE activity in various organ domains according to SLEDAI-2 K and BILAG-2004 indices at inception visit. (PDF 853 kb)